Can I split a 15 mg meloxicam (Muvera, Sun Pharma) tablet in half to take a 7.5 mg daily dose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Muvera 15mg (Meloxicam) Tablets Be Split in Half?

No, splitting meloxicam 15 mg tablets to achieve a 7.5 mg dose is not recommended due to significant concerns about dose accuracy and weight uniformity, particularly for this specific medication.

Evidence Against Splitting Meloxicam Tablets

Poor Weight and Content Uniformity

  • Meloxicam specifically failed both weight and content uniformity testing when split, with more than 10% of half tablets falling outside acceptable specifications in controlled studies 1.
  • In a systematic analysis of 16 commonly split medications, meloxicam was among the drugs that showed unacceptable variation in drug content after splitting, meaning you cannot reliably achieve a 7.5 mg dose by cutting a 15 mg tablet 1.

Clinical Implications of Dose Variability

  • Meloxicam has a narrow therapeutic window as a COX-2 selective NSAID, where the standard dosing is precisely 7.5 mg daily (increased to maximum 15 mg if necessary, with 7.5 mg maximum for elderly patients) 2.
  • The drug is more than 99.5% protein-bound with a 20-hour elimination half-life, meaning inconsistent dosing from split tablets could lead to either subtherapeutic effects or increased risk of serious gastrointestinal adverse events including ulceration and bleeding 2, 3.

Safer Alternative Approach

Obtain the Correct Tablet Strength

  • Request a prescription for meloxicam 7.5 mg tablets instead of attempting to split 15 mg tablets 2.
  • Meloxicam is manufactured in both 7.5 mg and 15 mg strengths specifically to provide accurate dosing without the need for tablet splitting 2.

Why Manufacturer Provides Multiple Strengths

  • Similar to finerenone (Kerendia), which is supplied in 10 mg and 20 mg tablets specifically engineered to eliminate any clinical need for tablet splitting, meloxicam's availability in 7.5 mg strength reflects deliberate design to avoid splitting-related dosing errors 4.

General Tablet Splitting Considerations

While some medications can be safely split (such as phentermine, where half tablets of 18.75 mg are explicitly mentioned as adequate dosing options) 5, meloxicam does not fall into this category based on experimental evidence 1.

When Tablet Splitting May Be Acceptable

  • Medications with wide therapeutic indices and long half-lives are more suitable candidates for division 1.
  • Tablets must pass weight and content uniformity specifications (90-110% of target dose) 1.
  • Patients must have physical capability to split tablets accurately 6.

The safest approach is to obtain meloxicam 7.5 mg tablets from your pharmacy rather than splitting 15 mg tablets, as this ensures accurate dosing and minimizes risk of NSAID-related adverse events.

References

Research

Meloxicam.

Profiles of drug substances, excipients, and related methodology, 2020

Research

Clinical pharmacokinetics of meloxicam.

Arzneimittel-Forschung, 1997

Guideline

Dosing and Monitoring of Finerenone (Kerendia) – No Tablet Splitting

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Tablet splitting].

Therapeutische Umschau. Revue therapeutique, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.